검색어 : 통합검색[San Diego Opera]
-
11
-
Why would Musical Training Benefit the Neural Encoding of Speech? The OPERA Hypothesis
-
Patel, Aniruddh D.;
Department of Theoretical Neurobiology, The Neurosciences Institute San Diego, CA, USA;
(Frontiers in psychology,
v.2,
2011,
pp.142)
-
12
-
The Beginner’s Guide to Opera Stage Management: Gathering the Tools You Need to Work in Opera <b>The Beginner’s Guide to Opera Stage Management: Gathering the Tools You Need to Work in Opera</b> , by Danielle Ranno, New York, NY, Routledge, 2023, 210 pp., <tex> $128 (hardback), $</tex>32 (paperback), ISBN: 9780367497934.
-
Saraniero, Patricia;
Moxie Research, San Diego, California;
(The Journal of arts management, law, and society,
v.53,
2023,
pp.348-349)
-
13
-
Vulnerable Women on Screen and at Home: Soap Opera Consumption
-
Stern, Barbara B.;
Russell, Cristel Antonia;
Russell, Dale W.;
Rutgers Business School, Newark and New Brunswick;
180 University Avenue, Newark, NJ 07102;
Marketing Department at San Diego State University, 5500 Campanile Drive, San Diego, CA 92182-8239;
Amsterdam School of Communications Research at the University of Amsterdam, Kloveniersburgwal 48, 1012 CX Amsterdam, the Netherlands;
(Journal of macromarketing,
v.25,
2005,
pp.222-225)
-
14
-
Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples
-
Brachtel, Elena F.;
Operañ
a, Theresa N.;
Sullivan, Peggy S.;
Kerr, Sarah E.;
Cherkis, Karen A.;
Schroeder, Brock E.;
Dry, Sarah M.;
Schnabel, Catherine A.;
Department of Pathology, Massachusetts General Hospital, Boston, Massachusetts, USA;
Biotheranostics, Inc., San Diego, California, USA;
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA;
Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA;
Biotheranostics, Inc., San Diego, California, USA;
Biotheranostics, Inc., San Diego, California, USA;
Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA;
Biotheranostics, Inc., San Diego, California, USA;
(Oncotarget,
v.7,
2016,
pp.27220-27231)
-
15
-
Human CYP1A1<sup>GFP</sup> Expression in Transgenic Mice Serves as a Biomarker for Environmental Toxicant Exposure
-
Operañ
a, Theresa N.;
Nguyen, Nghia;
Chen, Shujuan;
Beaton, Deirdre;
Tukey, Robert H.;
Laboratory of Environmental Toxicology, Departments of Chemistry and Biochemistry and Pharmacology, University of California, San Diego, La Jolla, California 92093-0722;
Laboratory of Environmental Toxicology, Departments of Chemistry and Biochemistry and Pharmacology, University of California, San Diego, La Jolla, California 92093-0722;
Laboratory of Environmental Toxicology, Departments of Chemistry and Biochemistry and Pharmacology, University of California, San Diego, La Jolla, California 92093-0722;
Laboratory of Environmental Toxicology, Departments of Chemistry and Biochemistry and Pharmacology, University of California, San Diego, La Jolla, California 92093-0722;
To whom correspondence should be addressed at University of California, San Diego, Leichtag Biomedical Research Building, Room 211, La Jolla, CA 92093-0722. Fax: (858) 822-0363. E-mail: rtukey@ucsd.edu.;
(Toxicological sciences : an official journal of the Society of Toxicology,
v.95,
2007,
pp.98-107)
-
16
-
Multi-Institutional, Prospective Clinical Utility Study Evaluating the Impact of the 92-Gene Assay (CancerTYPE ID) on Final Diagnosis and Treatment Planning in Patients With Metastatic Cancer With an Unknown or Unclear Diagnosis
-
Thomas, Sachdev P.;
Jacobson, Lauren E.;
Victorio, Anthony R.;
Operañ
a, Theresa N.;
Schroeder, Brock E.;
Schnabel, Catherine A.;
Braiteh, Fadi;
Sachdev P. Thomas, Illinois Cancer Care, Peoria, IL, and VA Central California Health Care System, Fresno;
Lauren E. Jacobson, Santa Barbara Cottage Hospital, Santa Barbara;
Anthony R. Victorio, Yosemite Pathology Medical Group, Modesto;
Theresa N. Operañ
a, Brock E. Schroeder, and Catherine A. Schnabel, Biotheranostics, San Diego, CA;
and Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV.;
Sachdev P. Thomas, Illinois Cancer Care, Peoria, IL, and VA Central California Health Care System, Fresno;
Lauren E. Jacobson, Santa Barbara Cottage Hospital, Santa Barbara;
Anthony R. Victorio, Yosemite Pathology Medical Group, Modesto;
Theresa N. Operañ
a, Brock E. Schroeder, and Catherine A. Schnabel, Biotheranostics, San Diego, CA;
and Fadi Braiteh, Comprehensive Cancer Centers of Nevada, Las Vegas, NV.;
Sachdev P. Thomas, Illinois Cancer Care, Peoria, IL, and VA Central California Health Care System, Fresno;
Lauren E. Jacobson, Santa Barbara Cottage Hospital, San;
(Jco precision oncology,
v.2,
2018,
pp.1-12)
-
17
-
Complementary Co‐assembling Peptides: From In Silico Studies to In Vivo Application
-
Raspa, Andrea;
Saracino, Gloria A. A.;
Pugliese, Raffaele;
Silva, Diego;
Cigognini, Daniela;
Vescovi, Angelo;
Gelain, Fabrizio;
Center for Nanomedicine and Tissue Engineering (CNTE), A.O. Ospedale Niguarda Ca' Granda, Piazza dell'ospedale maggiore 3, 20162, Milan, Italy;
Center for Nanomedicine and Tissue Engineering (CNTE), A.O. Ospedale Niguarda Ca' Granda, Piazza dell'ospedale maggiore 3, 20162, Milan, Italy;
Biotechnology and Biosciences Department, University of Milan‐
Bicocca, Piazza della Scienza 2, Milan, 20126, Italy;
Center for Nanomedicine and Tissue Engineering (CNTE), A.O. Ospedale Niguarda Ca' Granda, Piazza dell'ospedale maggiore 3, 20162, Milan, Italy;
Center for Nanomedicine and Tissue Engineering (CNTE), A.O. Ospedale Niguarda Ca' Granda, Piazza dell'ospedale maggiore 3, 20162, Milan, Italy;
IRCCS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, Viale Cappuccini 1, San Giovanni Rotondo (FG), 71013, Italy;
Center for Nanomedicine and Tissue Engineering (CNTE), A.O. Ospedale Niguarda Ca' Granda, Piazza dell'ospedale maggiore 3, 20162, Milan, Italy;
(Advanced functional materials,
v.24,
2014,
pp.6317-6328)
-
18
-
BMHP1-Derived Self-Assembling Peptides: Hierarchically Assembled Structures with Self-Healing Propensity and Potential for Tissue Engineering Applications
-
Gelain, Fabrizio;
Silva, Diego;
Caprini, Andrea;
Taraballi, Francesca;
Natalello, Antonino;
Villa, Omar;
Nam, Ki Tae;
Zuckermann, Ronald N.;
Doglia, Silvia Maria;
Vescovi, Angelo;
IRCCS Casa Sollievo della Sofferenza, Opera di San Pio da Pietrelcina, San Giovanni Rotondo 71013, Italy;
Biotechnology and Biosciences Department, University of Milan-Bicocca, Piazza dell Scienza 2, Milan, 20126, Italy;
Biotechnology and Biosciences Department, University of Milan-Bicocca, Piazza dell Scienza 2, Milan, 20126, Italy;
Biotechnology and Biosciences Department, University of Milan-Bicocca, Piazza dell Scienza 2, Milan, 20126, Italy;
Consorzio Nazionale Interuniversitario per le Scienze fisiche della Materia (CNISM) UdR Milan-Bicocca, Milan, 20126, Italy;
Biotechnology and Biosciences Department, University of Milan-Bicocca, Piazza dell Scienza 2, Milan, 20126, Italy;
Department of Materials Science and Engineering, Seoul National University, Gwanak-gu, 151-742, Seoul, Korea;
Molecular Foundry, Lawrence Berkeley National Laboratory, 1 Cyclotron Road, Berkeley, California 94720, United States;
Consorzio Nazionale Interuniversitario per le Scienze fisiche della Mater;
(ACS nano,
v.5,
2011,
pp.1845-1859)
-
19
-
OP08 Long-term efficacy and pharmacodynamics of the anti-mucosal addressin cell adhesion molecule-1 (MAdCAM-1) monoclonal antibody SHP647 in Crohn’s disease: the OPERA II study
-
D’Haens, G;
Reinisch, W;
Lee, S D;
Tarabar, D;
Louis, E;
Kłopocka, M;
Klaus, J;
Schreiber, S;
Park, D I;
Hé
buterne, X;
Gorelick, K J;
Martin, S W;
Banerjee, A;
Nagy, P;
Wang, Y;
Cataldi, F;
Sandborn, W J;
Academic Medical Centre, Amsterdam, The Netherlands;
Medical University of Vienna, Vienna, Austria;
University of Washington, Seattle, WA, USA;
Clinic of Gastroenterology and Hepatology, Military Medical Academy, Belgrade, Serbia;
University Hospital of Liè
ge, Liè
ge, Belgium;
Nicolaus Copernicus University, Collegium Medicum in Bydgoszcz, Bydgoszcz, Poland;
University Hospital Ulm, Ulm, Germany;
University Hospital Schleswig-Holstein, Christian-Albrechts-University of Kiel, Kiel, Germany;
Kangbuk Samsung Hospital, Sungkyunkwan University, Seoul, South Korea;
University of Nice Sophia Antipolis, Hospital l’Archet, Nice, France;
Zymo Consulting Group, Newtown Square, PA, USA;
Pfizer, Cambridge, MA, USA;
Pfizer, Cambridge, MA, USA;
Shire, Zug, Switzerland;
Shire, Lexington, MA, USA;
Shire, Lexington, MA, USA;
University of California San Diego, La Jolla, CA, USA;
(Journal of Crohn’s and colitis,
v.13,
2019,
pp.S005-S006)
-
20
-
Phase II evaluation of anti-MAdCAM antibody PF-00547659 in the treatment of Crohn’s disease: report of the OPERA study
-
Sandborn, William J;
Lee, Scott D;
Tarabar, Dino;
Louis, Edouard;
Klopocka, Maria;
Klaus, Jochen;
Reinisch, Walter;
Hé
buterne, Xavier;
Park, Dong-Il;
Schreiber, Stefan;
Nayak, Satyaprakash;
Ahmad, Alaa;
Banerjee, Anindita;
Brown, Lisa S;
Cataldi, Fabio;
Gorelick, Kenneth J;
Cheng, John B;
Hassan-Zahraee, Mina;
Clare, Robert;
D’Haens, Geert R;
Department of Medicine, Division of Gastroenterology , University of California San Diego , La Jolla , California , USA;
Department of Medicine, Division of Gastroenterology , University of Washington , Seattle , Washington , USA;
Clinic of Gastroenterology and Hepatology , Military Medical Academy , Belgrade , Serbia;
Department of Gastroenterology , University Hospital CHU of Liege , Liè
ge , Belgium;
Department of Vascular Diseases and Internal Medicine , Nicolaus Copernicus University, Toruń
, Collegium Medicum in Bydgoszcz , Poland;
Department of Medicine , Universitatsklinikum Ulm , Ulm , Germany;
Department of Medicine, Division of Gastroenterology , Medical University of Vienna , Vienna , Austria;
Department of Medicine , Université
de Nice Sophia Antipolis, Hô
pita;
(Gut: journal of the British Society of Gastroenterology,
v.67,
2018,
pp.1824-1835)